BiondVax listed on the Tel Aviv Stock Exchange in June 2007, raising $3 million. The IPO included an issue of 3,530,000 ordinary shares and 350,000 warrants with a strike price of NIS 4.33.
On 8 December 2009, BiondVax executed a follow-on offering on the Tel Aviv Stock Exchange, raising $5.3 million. The offering included an issue of 5,000,000 shares and 1,250,000 warrants (Series 2) with a strike price of NIS 4.25.
Ordinary Shares
Symbol:
TASE: BNDX
Current Stock Price:
Listing Venue:
Tel Aviv Stock Exhange (TASE)
ISIN:
IL0011052045
Stock Price Chart:
First Trading Day:
18 June 2007
Number of Shares Listed for Trading: (as at 31 July 2011)
39,698,191
Historical Stock Prices:
Market Capitalization: (as at 31 July 2011)
NIS 69.0 mln
Warrants
Symbol:
TASE: BND.W2
Current Warrant Price:
Listing Venue:
Tel Aviv Stock Exhange (TASE)
ISIN:
IL0011166159
Warrant Price Chart:
First Trading Day:
13 December 2009
Number of Warrants Listed for Trading: (as at 31 July 2011)
1,429,789
Historical Warrant Prices:
Market Capitalization: (as at 31 July 2011)
NIS 1.1 mln
Source: TASE Website
BiondVax is included in the following TASE indices:
